Microglia-drive IRF8 upregulates complement pathway in Parkinson's disease

Area of Science:

• Neuroscience
• Genetics
• Immunology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting dopaminergic neurons in the substantia nigra.
• Glial cells, including microglia, are increasingly recognized for their role in PD pathogenesis.

Purpose of the Study:

• To investigate the roles of specific brain cell types and their genetic alterations in Parkinson's disease.
• To identify key genes and cellular mechanisms involved in PD pathology using bioinformatics and experimental models.

Main Methods:

• Utilized transcriptome datasets from the substantia nigra.
• Employed bioinformatics tools such as Cibersort and Weighted Gene Co-expression Network Analysis (WGCNA).
• Applied machine learning for hub gene identification and conducted cell and animal model experiments.

Main Results:

• Microglia were identified as the most relevant cell type associated with PD transcriptome data.
• IRF8 was identified as a hub gene significantly linked to PD and microglia.
• Increased IRF8+ microglia and elevated IRF8 expression were observed in PD models; IRF8 knockdown affected the complement pathway.

Conclusions:

• IRF8 plays a significant role in the functional regulation of microglia in the context of Parkinson's disease.
• The study highlights IRF8's potential involvement in microglial activation via the complement pathway in PD.
• This research provides insights into the cellular and genetic underpinnings of PD, focusing on microglial involvement.